| FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ... The Lancet Oncology 17 (6), 801-810, 2016 | 916 | 2016 |
| Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ... JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019 | 306 | 2019 |
| A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma PJ Hosein, J Macintyre, C Kawamura, JC Maldonado, V Ernani, ... BMC cancer 12, 1-7, 2012 | 262 | 2012 |
| Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma G Narayanan, PJ Hosein, G Arora, KJ Barbery, T Froud, AS Livingstone, ... Journal of Vascular and Interventional Radiology 23 (12), 1613-1621, 2012 | 261 | 2012 |
| Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma LG Feun, YY Li, C Wu, M Wangpaichitr, PD Jones, SP Richman, ... Cancer 125 (20), 3603-3614, 2019 | 152 | 2019 |
| A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era PJ Hosein, JC Maragulia, MP Salzberg, OW Press, TM Habermann, ... British journal of haematology 165 (3), 358-363, 2014 | 140 | 2014 |
| A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer PJ Hosein, G de Lima Lopes Jr, VH Pastorini, C Gomez, J Macintyre, ... American journal of clinical oncology 36 (2), 151-156, 2013 | 138 | 2013 |
| Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma G Narayanan, PJ Hosein, IC Beulaygue, T Froud, HJ Scheffer, SR Venkat, ... Journal of Vascular and Interventional Radiology 28 (3), 342-348, 2017 | 121 | 2017 |
| Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database V Vilchez, MB Shah, MF Daily, L Pena, CWD Tzeng, D Davenport, ... Hpb 18 (1), 29-34, 2016 | 97 | 2016 |
| Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma N Dempsey, JC Maldonado, A Loaiza-Bonilla, M Velez, L Carcas, ... Pancreatology 15 (6), 667-673, 2015 | 88 | 2015 |
| Utility of positron emission tomography scans in mantle cell lymphoma PJ Hosein, VH Pastorini, FM Paes, D Eber, JR Chapman, AN Serafini, ... American journal of hematology 86 (10), 841-845, 2011 | 70 | 2011 |
| Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy … J Datta, X Dai, A Bianchi, IDC Silva, S Mehra, VT Garrido, P Lamichhane, ... Gastroenterology 163 (6), 1593-1612, 2022 | 65 | 2022 |
| Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system PJ Hosein, A Echenique, A Loaiza-Bonilla, T Froud, K Barbery, CMR Lima, ... Journal of vascular and interventional radiology 25 (8), 1233-1239. e2, 2014 | 60 | 2014 |
| Radiopharmaceuticals: when and how to use them to treat metastatic bone pain FM Paes, V Ernani, P Hosein, AN Serafini The journal of supportive oncology 9 (6), 197-205, 2011 | 43 | 2011 |
| LMO 2 and BCL 6 are associated with improved survival in primary central nervous system lymphoma C Lossos, S Bayraktar, E Weinzierl, SF Younes, PJ Hosein, RJ Tibshirani, ... British journal of haematology 165 (5), 640-648, 2014 | 41 | 2014 |
| Ipilimumab/nivolumab therapy in patients with metastatic pancreatic or biliary cancer with homologous recombination deficiency pathogenic germline variants G Terrero, J Datta, J Dennison, DA Sussman, I Lohse, NB Merchant, ... JAMA oncology 8 (6), 938-940, 2022 | 34 | 2022 |
| A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non‐Hodgkin's lymphoma PJ Hosein, MD Craig, MS Tallman, RV Boccia, BL Hamilton, JJ Lewis, ... American journal of hematology 87 (1), 111-114, 2012 | 33 | 2012 |
| Severe colitis associated with docetaxel use: A report of four cases AF Carrion, PJ Hosein, EM Cooper, G Lopes, L Pelaez, CM Rocha-Lima World journal of gastrointestinal oncology 2 (10), 390, 2010 | 33 | 2010 |
| A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ... The Lancet. Oncology 17 (6), 801, 2016 | 31 | 2016 |
| Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma IS Lossos, JC Fabregas, T Koru-Sengul, F Miao, D Goodman, AN Serafini, ... Leukemia & lymphoma 56 (6), 1750-1755, 2015 | 30 | 2015 |
Govindarajan NarayananMiami Cancer Institute在 baptisthealth.net 的电子邮件经过验证
